Y010-0300 Screening compound: 1-(3,4-dichlorophenyl)-3-(4-phenyl-1,3-thiazol-2-yl)urea

Y010-0300 Screening compound: 1-(3,4-dichlorophenyl)-3-(4-phenyl-1,3-thiazol-2-yl)urea
Y010-0300 Screening compound: 1-(3,4-dichlorophenyl)-3-(4-phenyl-1,3-thiazol-2-yl)urea alternative view

Chemical Structure Depiction of ChemDiv screening compound Y010-0300
1-(3,4-dichlorophenyl)-3-(4-phenyl-1,3-thiazol-2-yl)urea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y010-0300

Molecular Formula

C16H11Cl2N3OS (C16 H11 Cl2 N3 OS)

Compound Name

1-(3,4-dichlorophenyl)-3-(4-phenyl-1,3-thiazol-2-yl)urea

IUPAC name

1-(34-dichlorophenyl)-3-(4-phenyl-13-thiazol-2-yl)urea

SMILES

O=C(Nc1nc(-c2ccccc2)cs1)Nc(cc1)cc(Cl)c1Cl

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

364.25

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.495

Distribution Coefficient, logD

6.495

Water Solubility, LogSw

-6.47

Polar Surface Area

42.316

Acid Dissociation Constant (pKa)

10.87

Base Dissociation Constant (pKb)

1.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

Y010-0300 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

CNS targets activity set (6557 compounds)

Human GPCR Annotated Library (5539 compounds)

Proline Kinase Library (2105 compounds)

Selective Target Activity Profiling Library (14702 compounds)

SmartTM Library (51161 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Nervous system
  • Male
  • Female
  • Endocrine
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with Y010-0300 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y010-0300?
Check Price and Availability of Y010-0300, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y010-0300 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y010-0300
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y010-0300
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y010-0300 available by request